A 68-year-old woman presented to the emergency room with pleuritic left-sided chest pain associated with shortness of breath and a productive cough with clear sputum but no hemoptysis.
In this video, Zeenat Safdar, MD, MS, a STELLAR trial investigator, discusses the STELLAR trial results, which supported the FDA approval of sotatercept. Sotatercept is the first activin signaling inhibitor...
The FDA has approved sotatercept-csrk, the first activin signaling inhibitor therapy, for the management of patients with pulmonary arterial hypertension (PAH). Based on the Phase 3 STELLAR trial,...
Bacterial and viral infections may play key roles in asthma exacerbations and even in development of asthma among youth. Which side of the debate do you stand on?
In this video, Zeenat Safdar, MD, MS, a STELLAR trial investigator, discusses the STELLAR trial results, which supported the FDA approval of sotatercept. Sotatercept is the first activin signaling inhibitor...
In this video, Maura Marcucci, MD, MSc, discusses her study's surprising results, which showed no differences between hypotension-avoidance and hypertension-avoidance strategies for decreasing adverse...
Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
In this video, Albert Rizzo, MD, speaks with allergist and immunologist Juanita Mora, MD, pediatrician John Harrington, MD, and pulmonary and critical care physician, David Hill, MD about updates to the...
Are there benefits to vaccinating women who are pregnant with a vaccine that prevents respiratory syncytial virus (RSV)-related illness in newborns? A new study examined this topic.
